Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
Authors
Keywords
Bone metastasis, Prognostic factors, Renal cell carcinoma, Time to distant metastasis
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 34, Issue 1, Pages 10
Publisher
Springer Nature
Online
2015-02-04
DOI
10.1186/s13046-015-0122-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma
- (2015) Matteo Santoni et al. JOURNAL OF UROLOGY
- High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor
- (2014) Elke Joeckel et al. Molecular Cancer
- Cadherin-11 in Renal Cell Carcinoma Bone Metastasis
- (2014) Robert L. Satcher et al. PLoS One
- Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside
- (2013) Matteo Santoni et al. CANCER AND METASTASIS REVIEWS
- Survival Outcome and Treatment Response of Patients with Late Relapse from Renal Cell Carcinoma in the Era of Targeted Therapy
- (2013) Nils Kroeger et al. EUROPEAN UROLOGY
- Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis
- (2013) Yunzhen Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey
- (2013) Daniele Santini et al. PLoS One
- Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma
- (2012) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- In vitro the behaviors of metastasis with suppression of VEGF in human bone metastatic LNCaP-derivative C4-2B prostate cancer cell line
- (2012) Lei Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
- (2011) A Shiirevnyamba et al. BRITISH JOURNAL OF CANCER
- Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib
- (2010) B. Beuselinck et al. ANNALS OF ONCOLOGY
- Skeletal complications and survival in renal cancer patients with bone metastases
- (2010) Emma Woodward et al. BONE
- Renal cell carcinoma bone metastases: clinical advances
- (2010) Chakshu Sahi et al. Therapeutic Advances in Medical Oncology
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib for Metastatic Renal Cancer
- (2008) Rachel P. Riechelmann et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started